In this context, we previously reported that the co-administration of leptin and a PTP1B inhibitor, which enhanced leptin receptor signaling, improved glucose metabolism in a mouse model of IDDM [20]. The gene discussed is PTPN1; the disease is type 1 diabetes mellitus.